Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis

FASEB J. 2004 Feb;18(2):370-2. doi: 10.1096/fj.03-0708fje. Epub 2003 Dec 19.

Abstract

Experimental sepsis in rodents occurring after cecal ligation/puncture (CLP) is associated with excessive complement activation and a systemic inflammatory response. The proinflammatory mediator IL-6 has recently been shown to be an important inducer of the C5a receptor (C5aR) during sepsis. We now provide evidence that serum IL-6 production during sepsis in rats was reduced in neutrophil-depleted animals and that absence of C5aR in mice as well as antibody-blockade of C5a in rats significantly reduced serum levels of IL-6 during sepsis. Lipopolysaccharide (LPS)-induced production in vitro of IL-6 by neutrophils was significantly enhanced in the co-presence of C5a, likely due to transcriptional up-regulation of IL-6. Production of IL-6 in neutrophils by LPS was NF-kappaB dependent (but not on the presence of p50) and dependent on phosphorylation of p38-mitogen activated protein kinase (MAPK) as well as p44/p42 MAPK (ERK1/2) but not on phosphorylation of c-Jun N-terminal kinases (JNK1/2). C5a stimulation of neutrophils elicited a rapid phosphorylation of ERK1/2 and p38 MAPK. Accordingly, we suggest that induction of IL-6 after CLP is neutrophil and C5a/C5aR dependent, likely due to the ability of C5a to cause activation of ERK1/2 and p38 MAPK signaling pathways.

MeSH terms

  • Animals
  • Complement C5a / antagonists & inhibitors
  • Complement C5a / pharmacology*
  • Gene Expression Regulation / drug effects
  • Interleukin-6 / biosynthesis
  • Interleukin-6 / blood
  • Interleukin-6 / genetics
  • Lipopolysaccharides / pharmacology*
  • MAP Kinase Signaling System / drug effects
  • Mice
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / metabolism
  • Models, Biological
  • NF-kappa B / metabolism
  • Neutrophils / drug effects
  • Neutrophils / metabolism
  • Rats
  • Receptor, Anaphylatoxin C5a / antagonists & inhibitors
  • Receptor, Anaphylatoxin C5a / genetics
  • Receptor, Anaphylatoxin C5a / metabolism
  • Sepsis / blood
  • Sepsis / immunology

Substances

  • Interleukin-6
  • Lipopolysaccharides
  • NF-kappa B
  • Receptor, Anaphylatoxin C5a
  • Complement C5a
  • Mitogen-Activated Protein Kinases